Back
Delegates Premium Access

Comparative effectiveness of pharmacologic agents for heart failure prevention in post-myocardial infarction patients: A comprehensive Bayesian network meta-analysis

Session: Pharmacological and non-pharmacological interventions in heart failure
Topic: Secondary Prevention
Speaker: Doctor V. Lanari (Milan, IT)
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Valeria Chiara Lanari

Milan (Italy)
0 follower

5 more presentations in this session

Eccentric overload training in patients with heart failure: assessing delayed onset muscle soreness to determine feasibility

Speaker: Mr S. Naessens (Antwerpen, BE)

Access
Abstract
Slides
Like
Thumbnail

Heart failure and early cardiac rehabilitation: pilot experience and definition of the patient journey

Speaker: Doctor F. Di Salvo (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Growth hormone replacement therapy in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial

Speaker: Associate Professor A. Marra (Naples, IT)

Access
Abstract
Slides
Like
Thumbnail

The correlation between the modifiable risk factors in hospital readmissions and critical phase in heart failure patients

Speaker: Doctor A. Lacraru (Bucharest, RO)

Access
Abstract
Slides
Like
Thumbnail

Effects of an in-hospital physical activity motivational programme in chronic heart failure or chronic obstructive pulmonary disease patients undergoing rehabilitation: a randomized controlled trial

Speaker: Doctor C. Simonelli (Lumezzane, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Pharmacological and non-pharmacological interventions in heart failure

Speakers: Doctor V. Lanari, Mr S. Naessens, Doctor F. Di Salvo, Associate Professor A. Marra, Doctor A. Lacraru...
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources